Company Filing History:
2 out of 67 
1 out of 7 Years Active: 2002-2008
Title: The Innovative Contributions of Catherine Marie Ghislaine Gerard
Introduction
Catherine Marie Ghislaine Gerard is a notable inventor based in Rhode-Saint-Genese, Belgium. She has made significant contributions to the field of vaccine development, holding a total of three patents. Her work focuses on enhancing vaccine efficacy through innovative adjuvant compositions.
Latest Patents
Gerard's latest patents revolve around adjuvant compositions suitable for use in vaccines. These compositions include a saponin and an immunostimulatory oligonucleotide, which may be combined with a carrier. The patents also detail the vaccines that incorporate these adjuvants along with an antigen. Furthermore, they outline methods for manufacturing these adjuvants and vaccines, as well as their application as medicaments. Gerard's inventions provide methods for treating individuals who are susceptible to or suffering from diseases through the administration of these vaccines.
Career Highlights
Throughout her career, Catherine Gerard has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Biologicals. Her expertise in vaccine development has positioned her as a key figure in the field, contributing to advancements that have the potential to improve public health.
Collaborations
Gerard has collaborated with esteemed colleagues such as Martin Friede and Nathalie Garcon. These partnerships have further enriched her research and development efforts in vaccine technology.
Conclusion
Catherine Marie Ghislaine Gerard's innovative work in vaccine adjuvant compositions highlights her significant role in the advancement of medical science. Her contributions continue to pave the way for improved treatments and preventive measures against diseases.